A detailed history of Sachetta, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Sachetta, LLC holds 23 shares of CTLT stock, worth $1,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 23 -0.0%
Holding current value
$1,403
Previous $1.36 Million 2.65%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$53.58 - $57.02 $696 - $741
13 Added 130.0%
23 $1.36 Million
Q4 2023

Feb 09, 2024

BUY
$32.18 - $46.57 $321 - $465
10 New
10 $450,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.